tiprankstipranks
Theralase Technologies (TSE:TLT)
:TLT
Canadian Market

Theralase Technologies (TLT) Income Statement

Compare
85 Followers

Theralase Technologies Income Statement

Last quarter (Q3 2024), Theralase Technologies's total revenue was C$346.58K, an increase of 23.51% from the same quarter last year. In Q3, Theralase Technologies's net income was C$-937.53K. See Theralase Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 1.07MC$ 1.14MC$ 780.64KC$ 929.12KC$ 964.05K
Gross Profit
C$ 562.13KC$ 628.17KC$ 309.94KC$ 269.68KC$ 60.76K
Operating Expenses
C$ 5.15MC$ 5.86MC$ 4.85MC$ 5.97MC$ 7.48M
Depreciation and Amortization
C$ 286.12KC$ 313.23KC$ 276.15KC$ 272.28KC$ 255.26K
EBITDA
C$ -4.25MC$ -4.90MC$ -4.31MC$ -5.56MC$ -7.15M
Operating Income
C$ -4.59MC$ -5.20MC$ -4.52MC$ -5.59MC$ -7.39M
Other Income/Expenses
C$ 23.39KC$ -3.76KC$ 130.48KC$ 124.03KC$ 6.21K
Pretax Income
C$ -4.57MC$ -5.24MC$ -4.41MC$ -5.60MC$ -7.41M
Net Income
C$ -4.57MC$ -5.25MC$ -4.42MC$ -5.61MC$ -7.43M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.02C$ -0.03C$ -0.02C$ -0.03C$ -0.05
Diluted EPS
C$ -0.02C$ -0.03C$ -0.02C$ -0.03C$ -0.05
Weighted Average Shares Outstanding
219.97M 207.92M 204.28M 204.28M 144.68M
Weighted Average Shares Outstanding (Diluted)
219.97M 207.92M 204.28M 204.28M 144.68M
Currency in CAD

Theralase Technologies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis